FDAnews Drug Daily Bulletin

SOLVAY PHARMACEUTICALS SETTLES LAWSUIT AGAINST PSEUDO-GENERIC TO CREON MINIMICROSPHERES

July 12, 2006
A A

Solvay Pharmaceuticals, Inc. announced today that it has settled a lawsuit filed against Global Pharmaceuticals and Impax Laboratories, Inc. alleging that the companies falsely advertised and marketed their products as generic equivalents to and substitutes for Solvay Pharmaceuticals' CREON MINIMICROSPHERES (Pancrelipase Delayed-release Capsules, USP).

Yahoo Finance (http://biz.yahoo.com/bw/060711/20060711005704.html?.v=1)